<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2007</study_start_year><condition>Colorectal Neoplasms</condition><condition>Advanced Colorectal Cancer</condition><disease>Colorectal Neoplasms</disease><disease>Advanced Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2027665</full_dataset_link><location>Canada</location><location>United States</location><study_start_month>9</study_start_month><keyword>Cetuximab</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors</name><description>This study proposes to determine the safety of the administration of E7820 plus cetuximab and explore the MTD of the combination in a Phase Ib study. In addition, the efficacy of this combination will be explored in patients with colorectal cancer in the Phase II proof of concept phase of the study.</description><dates><creation>2007-09-15</creation></dates><accession>2027665</accession><cross_references><ClinicalTrials___gov>NCT00309179</ClinicalTrials___gov></cross_references></HashMap>